- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06206057
The Relationship Between Leisure Activities and Aging Anxiety in Women
The Relationship Between Leisure Activities and Aging Anxiety in Middle-aged Women
Study Overview
Status
Conditions
Detailed Description
In this study, women aged between 40 and 59 registered at the Marmara University Education Family Health Center (FHC) in the Tuzla district will be included. There are a total of 352 women in this age range registered with the FHC, and it is aimed to reach all of them.
Patients will be informed about the study by Dr. Buğu Usanma Koban via telephone, and they will be invited to the FHC for the administration of the questionnaire. After obtaining informed consent from those who agree to participate in the study, their personal information will be recorded through a face-to-face interview. Subsequently, the Aging Anxiety Scale for Middle-Aged Women, developed by Lee and You, and validated in Turkish by Aydın and Kabasakal, will be applied to the participants.
Finally, volunteers will be asked to fill out a questionnaire specifying the types and frequencies of their leisure activities. SPSS (version 20.0, SPSS Inc., Chicago, IL, USA) will be used for data analysis.
Descriptive statistical information will be presented as mean ± standard deviation or %, and a p-value less than 0.05 will be considered statistically significant. In the comparison of more than two independent groups that do not meet the assumptions of parametric tests, the Kruskal-Wallis analysis will be conducted. If the analysis is significant, groups will be subjected to pairwise Mann-Whitney U tests.
To understand the relationship between leisure activities and aging anxiety, Spearman Correlation Analysis will be conducted for parameters conforming to normal distribution, and Pearson Correlation Analysis will be performed for parameters not conforming to normal distribution. The correlation coefficient (r value) will be specified.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Buğu Usanma Koban, Asst Dr
- Phone Number: 00905062041996
- Email: buguukoban@gmail.com
Study Locations
-
-
Tuzla
-
İstanbul, Tuzla, Turkey
- Marmara University Education Family Healthcare Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Not having a medical condition that requires urgent intervention or hospitalization
- Not having psychological or physical barrier preventing communication.
Exclusion Criteria:
- a medical condition that requires urgent intervention or hospitalization
- having a psychological or physical barrier preventing communication.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of leisure activities on aging anxiety
Time Frame: 3 months
|
Relationship between leisure activities' type and frequency, and scores of Aging Anxiety Scale for Middle-Aged Women will be investigated. The scale consists of 19 questions and is scored on a 5-point Likert scale. The highest possible score on the scale is 95, and the lowest score is 19. Obtaining a high score indicates a high level of aging anxiety. |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sociodemographic properties and aging anxiety
Time Frame: 3 months
|
In the form created for collecting sociodemographic information, marital status (married, single, widowed/divorced) and educational status (illiterate, literate, primary school graduate, high school graduate, university and college graduate) will be queried. The correlation between the answers and the scores on the "Aging Anxiety Scale for Middle-Aged Women" will be examined. The scale consists of 19 questions and is scored on a 5-point Likert scale. The highest possible score on the scale is 95, and the lowest score is 19. Obtaining a high score indicates a high level of aging anxiety. |
3 months
|
Effect of chronic diseases on aging anxiety
Time Frame: 3 months
|
Correlation between number and type of chronic diseases and the scores on the "Aging Anxiety Scale for Middle-Aged Women" will be examined. The scale consists of 19 questions and is scored on a 5-point Likert scale. The highest possible score on the scale is 95, and the lowest score is 19. Obtaining a high score indicates a high level of aging anxiety. |
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Buğu Usanma Koban, Asst Dr, Marmara University Medical School
Publications and helpful links
General Publications
- Barrett AE, Robbins C. The multiple sources of women's aging anxiety and their relationship with psychological distress. J Aging Health. 2008 Feb;20(1):32-65. doi: 10.1177/0898264307309932. Epub 2007 Dec 18.
- Barrett AE, Toothman EL. Multiple "Old Ages": The Influence of Social Context on Women's Aging Anxiety. J Gerontol B Psychol Sci Soc Sci. 2018 Oct 10;73(8):e154-e164. doi: 10.1093/geronb/gbx027.
- Oh A, Kim J, Yi E, Shin J. Verification of the Mediating Effect of Social Support on Physical Activity and Aging Anxiety of Korean Pre-Older Adults. Int J Environ Res Public Health. 2020 Nov 2;17(21):8069. doi: 10.3390/ijerph17218069.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.2023.1457
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Consciousness and Healing InitiativeNot yet recruitingAnxiety | Anxiety State | Mental Health Issue | Anxiety Generalized
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom